Naba Alsaha Medical Services Company
9546.SRSAUHealthcare● Active
$22.85
+$0.45(+2.01%)
Market Cap$479850000
P/E Ratio—
52W High$34.65
52W Low$20.37
Naba Alsaha Medical Services Company (9546.SR) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · 9546.SR · as of 2026-06-15
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.20B | $0.19B | $0.18B | $0.13B | $0.12B |
| Cost of Revenue | $0.14B | $0.13B | $0.11B | $0.08B | $0.07B |
| Gross Profit | $0.07B | $0.06B | $0.07B | $0.05B | $0.05B |
| Gross Margin %(computed) | 32.80% | 32.10% | 40.45% | 39.82% | 39.75% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| G&A Expenses | $0.01B | $0.01B | $0.01B | $0.00B | $0.00B |
| Total Operating Expenses | $0.04B | $0.04B | $0.03B | $0.02B | $0.02B |
| Operating Income | $0.03B | $0.03B | $0.04B | $0.03B | $0.03B |
| Operating Margin %(computed) | 15.26% | 12.99% | 23.56% | 21.83% | 22.92% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | $0.03B | $0.03B | $0.05B | $0.03B | $0.03B |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Income | $0.03B | $0.02B | $0.05B | $0.03B | $0.03B |
| Net Margin %(computed) | 13.64% | 11.21% | 28.73% | 20.76% | 21.95% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $1.31 | $1.03 | $2.50 | $1.28 | $1.23 |
| Wtd Avg Shares | 0.02B | 0.02B | 0.02B | 0.02B | 0.02B |
| EBITDA | $0.04B | $0.04B | $0.07B | $0.04B | $0.03B |
| EBITDA Margin %(computed) | 21.48% | 19.42% | 35.80% | 27.79% | 28.81% |
Data source: Financial Modeling Prep · Last updated: 2026-06-15 · SAR · B
Explore more Naba Alsaha Medical Services Company data
About Naba Alsaha Medical Services Company (9546.SR) Income Statement
Naba Alsaha Medical Services Company (9546.SR) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, 9546.SR reported revenue of $0.20B, gross profit of $0.07B (gross margin 32.80%), and net income of $0.03B — a net profit margin of 13.64%.
Frequently asked questions
9546.SR · 4 questionsNaba Alsaha Medical Services Company (9546.SR) reported revenue of $0.20B for 2025, up 3.9% year-over-year.
9546.SR revenue9546.SR salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-15